[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 13, 1997

Microbial Drug Resistance

Author Affiliations

Massachusetts College of Pharmacy and Allied Sciences Boston

 

edited by Alexander Tomasz, quarterly, $97 (individual), $196 (institutional), New York, NY, Mary Ann Liebert, spring 1995—.

JAMA. 1997;278(6):523. doi:10.1001/jama.1997.03550060099047

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

The stated intention of Microbial Drug Resistance is to be "an international journal that provides a multi-disciplinary forum for peer reviewed original papers as well as topical reviews and special reports." It focuses primarily upon "the emergence and spread of antibiotic-resistant microbial pathogens and resistance genes, and the challenges they present to a wide range of disciplines."

Boasting an international editorial board principally comprised of researchers with a small representation of clinicians, this journal appears to be only partially fulfilling its goals. Most studies published in the first four issues have focused on in vitro research in microbial resistance and identification of genes associated with this resistance. These articles generally represent high-quality communications in both content and presentation, are well-referenced, and contain good graphics.

Yet, the extremely narrow focus of the subject matter would seem to preclude a readership far beyond those involved in basic microbial research. Most clinicians would

×